Study to assess the efficacy and safety of treatment with FOLFIRI-aflibercept compared to initial treatment with FOLFIRI-aflibercept (for 6 cycles) followed by maintenance with 5FU-aflibercept, in an elderly population with metastatic colorectal cancer after failure of an oxaliplatin-based regimen

ABSTRACT: Primary objectives: To assess the non inferiority of aflibercept + 5FU/LV as maintenance vs aflibercept+ FOLFIRI with progression free survival (PFS) as the primary outcome parameterin elderly patients (≥70 years). Primary endpoints: Progression-free survival

DISEASE(S): Metastatic Colorectal Cancer,Cáncer Colorrectal Metastásico

PROVIDER: 2536279 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR